Figure 1
From: Topical netarsudil for the treatment of primary corneal endothelial degeneration in dogs

Study design depicting allocation of dogs to groups and their duration of treatment. Canine patients were divided into vehicle treatment group (n = 11) and netarsudil treatment group (n = 10). Of the 11 dogs enrolled in the vehicle treatment group, 2 dogs were treated for 4 months with vehicle only, 5 dogs were treated for 4 months with vehicle then 4 months with netarsudil, and 4 dogs were treated for 4 months with vehicle then 8 months with netarsudil. Of the 10 dogs enrolled in the netarsudil treatment group, 1, 4 and 5 dogs were treated for 4, 8 and 5 months, respectively.